General News

General News | Mar. 09, 2011

LFA Applauds FDA Decision to Approve Benlysta for the Treatment of Lupus

The U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease.

General News | Feb. 08, 2011

Human Genome Sciences and GlaxoSmithKline Announce Publication Phase 3 Study Results for BENLYSTA®

Human Genome Sciences and GlaxoSmithKline announced publication of the BLISS-52 study of BENLYSTA®.